Global Human African Trypanosomiasis (Sleeping Sickness) Market - Industry Trends and Forecast to 2028

1. Global Human African Trypanosomiasis (Sleeping Sickness) Market - Industry Trends and Forecast to 2028 The global human African trypanosomiasis (sleeping sickness) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 7.0% in the above-mentioned research forecast period. Human African trypanosomiasis (HAT), usually known as sleeping sickness is a vector-borne disease affecting humans in Sub-Saharan Africa. It is caused by parasitic protists of the species, https://www.databridgemarketresearch.com/reports/global-human-african-trypanosomiasis-sleeping-sickness-market Trypanosoma brucei. It's two sub-species that can infect humans are gambiense and rhodesiense. Both types of the parasite are typically transmitted to humans via infected tsetse (genus Glossina), Tsetse is a large biting fly that dwells in affected regions. The parasites first develop in the blood, lymph and peripheral organs (stage 1) and further spread to the central nervous system (stage 2), where they cause severe neurological disorders. The diseases caused by these infections are generally fatal without treatment.

2. Report Description https://www.databridgemarketresearch.com/reports/global-human-african-trypanosomiasis-sleeping-sickness-market HAT is known to occur in rural areas of 36 countries in sub-Saharan Africa, where tsetse flies are endemic. T. b. gambiense is found in Central, West and some parts of Eastern Africa, whereas T. b. rhodesiense is found in southern and Eastern Africa. Of the estimated 10 000–30 000 cases in endemic areas of Africa, more than 95% of these cases are due to T. b. gambiense HAT. In the cases presented here, approximately 30% of cases were due to T. b. gambiense HAT and 70% were due to T. b. rhodesiense HAT. The major problem in non-endemic regions is an initial misdiagnosis, mostly of T. b. gambiense HAT. The chronic nature, characterized by non-specific clinical signs and symptoms, and low parasitemia, may result in the disease remaining undiagnosed and unrecognized for years. Another problem was complicating the management of patients is the availability of drugs to treat HAT. General recommendations to prevent tsetse-fly">tsetse fly bites include wearing light-colored clothing that fully covers the arms and legs, as well as the use of personal insecticides. The most effective means for preventing /trypanosomiasis">trypanosomiasis, both in travelers and in those living in endemic areas, is the control and reduction of vectors and reservoirs.

3. Market Overview The governments of disease-endemic countries are committed to controlling the disease and several initiatives to coordinate efforts have begun. These include the Pan-African Tsetse and Trypanosomiasis Eradication Campaign and the Programme against African Trypanosomiasis.  The development of vaccines aimed to reduce T.b. transmission through immunization against insect parasite stages which express an invariant glycoprotein coat that is, blocking the parasitemia onset in the host, as the successful anti-tick vaccine. Several antigens have been already proposed as candidates for such experimental vaccination schemes and are being tested. Only four drugs are approved to treat HAT. However, eflornithine and pentamidine are ineffective against sleeping sickness caused by T.b. rhodesiense. Treatment with melarsoprol, the only generally effective first-line drug, required lengthy parenteral administration and can result in up to 10% mortality. Additionally, the toxicity and the upsurge in the number of patients failing to respond to melarsoprol because of drug resistance reflect the need for the discovery of new chemotherapeutic agents against HAT. To this effect, the insufficiency of current therapies for the treatment and management of trypanosomiasis, combined with both a lack of trust in conventional medical treatment and an inability of the economy to absorb the cost of pharmaceuticals, have created a growing public interest in alternative natural drugs from botanicals. This human African trypanosomiasis (sleeping sickness) market provides details of market share, new developments and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the human African trypanosomiasis (sleeping sickness) market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

4. Key Players Competitive Landscape and Human African Trypanosomiasis (Sleeping Sickness) Market Share Analysis The human African trypanosomiasis (sleeping sickness)market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the human African trypanosomiasis (sleeping sickness) market. The major players covered in the human African trypanosomiasis (sleeping sickness) market are Sara Healthcare Pvt. Ltd, Bayer Pharmaceutics Company, ScinopharmTaiwan.Ltd, Micro OrgoChem, Rusan Pharma Ltd, Sanofi-Aventis groupe among others domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com